Below please find link(s) to new coronavirus-related content published today in Annals of Internal Medicine. All coronavirus-related content published in Annals of Internal Medicine is free to the public. A complete collection is available at https://annals.org/aim/pages/coronavirus-content
Even if fatality rates are at the lower end of expectations -- one percent of virus victims -- it is highly likely that death and bereavement services will be overwhelmed, according to newly-published research by Dr Julia Meaton, Dr Anna Williams and researcher Helen-Marie Kruger.
A review of published data and analysis on the Spanish flu, found that cities that adopted early and broad isolation and prevention measures had disease and mortality rates that were 30% to 50% lower than other cities.
Gene therapy investigators can greatly benefit from the resources and services provided by the National Gene Vector Biorepository (NGVB), housed at the Indiana University School of Medicine.
In the current situation when the fear of virus infections in the public is common, it is good to remember that some viruses can be extremely beneficial for mankind, even save lives. Such viruses, phages, infect bacteria. The research conducted at the University of Jyväskylä shed some light on the phage therapy history. It revealed that Brazil was a strong user and developer of phage therapy in 1920-40's. The research was published in Lancet Infectious Diseases -publication on March 2020.
An overview of the basics of coronaviruses, with a focus on coronavirus disease 2019 (COVID-19) along with their effects on the cardiovascular system.
A description of the presentation of acute myocardial inflammation in a patient with coronavirus disease 2019 (COVID-19) who recovered from influenzalike syndrome and developed fatigue and signs and symptoms of heart failure a week after upper respiratory tract symptoms.
Evaluating the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).
COVID-19 can have fatal consequences for people with underlying cardiovascular disease and cause cardiac injury even in patients without underlying heart conditions, according to a review published today in JAMA Cardiology by experts at The University of Texas Health Science Center at Houston (UTHealth).
Aminoglycoside antibiotics are critically important for treating several types of infections with multi-resistant bacteria. A completely new resistance gene, which is likely to counteract the newest aminoglycoside-drug plazomycin, was recently discovered by scientists in Gothenburg, Sweden.